ROBAXISAL C 1/4
ROBAXISAL C 1/4
Approved
DIN Number
01934783
Drug Class
Human
Market Date
Dec 31, 1992
Company
HC
glaxosmithkline consumer healthcare ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number01934783
AIG Number0301256003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Narcotic (CDSA I)
A
ATC Code
N02AA59 CODEINE, COMBINATIONS EXCL. PSYCHOLEPTICS
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:08.08
Health Canada Classification
ACTIVE INGREDIENTS (3)
ACETYLSALICYLIC ACIDActive
Strength: 325 MG
Monograph: ACETYLSALICYLIC ACID
CODEINE PHOSPHATEActive
Strength: 16.2 MG
Monograph: CODEINE PHOSPHATE
METHOCARBAMOLActive
Strength: 400 MG
Monograph: METHOCARBAMOL